Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Shares Sold by Avidity Partners Management LP

Avidity Partners Management LP lessened its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 96.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,501 shares of the company’s stock after selling 1,692,439 shares during the quarter. Avidity Partners Management […]

Related Keywords

Switzerland ,Canada ,United States ,Swiss ,Leerink Partnrs ,Nasdaq ,Swiss National Bank ,Amylyx Pharmaceuticals Stock Down ,Amylyx Pharmaceuticals Inc ,Janney Montgomery Scott ,Amylyx Pharmaceuticals Profile ,Rafferty Asset Management ,Charles Schwab Investment Management Inc ,Amylyx Pharmaceuticals ,Quarter For Amylyx Pharmaceuticals ,News Ratings For Amylyx Pharmaceuticals Daily ,Avidity Partners Management ,Free Report ,Partners Management ,National Bank ,Montgomery Scott ,Schwab Investment Management ,Asset Management ,Aigen Investment Management ,Investment Management ,Pharmaceuticals Stock Down ,Get Free Report ,Visit Holdingschannel ,Amylyx Pharmaceuticals Daily ,